- Microneedling + minoxidil significantly outperforms minoxidil alone: Across 8 RCTs with 472 patients, the combination produced significantly more hair regrowth (mean difference: 15.82 more hairs, 95% CI: 12.34–19.31, p < 0.05)
- Shallower needles work better: Needles under 1 mm produced a larger effect (SMD: 1.16) than needles over 1 mm (SMD: 0.52), challenging the assumption that deeper is better
- 12 weeks is the sweet spot: 12-week protocols showed stronger effects (SMD: 1.08) than longer 21–24 week protocols (SMD: 0.64)
- Hair count improves, but not hair thickness: Microneedling significantly increased hair count but did not significantly change hair diameter (SMD: −0.21, p = 0.879)
- Consistent across studies: The benefit was statistically significant in every subgroup analysed: by needle depth and by treatment duration
| Study Design | Systematic review and meta-analysis of randomised controlled trials |
| Studies Included | 8 RCTs |
| Total Patients | 472 |
| Key Result | Hair count mean difference: 15.82 (95% CI: 12.34–19.31, p < 0.05) favouring MN + minoxidil |
| Evidence Level | Level 1a: Meta-analysis of RCTs |
| Authors | Chunyan Xu, Xingwu Duan, Qiang Yin, Keshuai Liu |
| Institution | Department of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine |
| Journal | Chinese Medicine and Natural Products, Vol. 4, Issue 1, pp. e8–e17 |
| Published | 30 March 2024 (Received: 2 Nov 2023; Accepted: 22 Dec 2023) |
| DOI | 10.1055/s-0044-1782181 |
| Study Type | Systematic review and meta-analysis of 8 RCTs (472 patients) |
Why This Research Matters
By 2024, multiple meta-analyses had confirmed that microneedling improves hair loss outcomes, but important practical questions remained unanswered. How deep should the needles go? How long should treatment last? These are the questions that matter most to someone deciding on a treatment protocol.
We fold these depth and duration findings into the complete microneedling for hair growth guide, as a step-by-step routine.
Xu et al.'s meta-analysis at Beijing University of Chinese Medicine addresses these questions directly. By pooling data from 8 randomised controlled trials with 472 patients and conducting subgroup analyses by needle depth and treatment duration, they provide the clearest picture yet of how to optimise microneedling for hair regrowth.
The most surprising finding: shallower needles (under 1 mm) produced a larger effect than deeper needles (over 1 mm). This challenges the common assumption that deeper penetration means better results, and aligns with the Faghihi 2021 depth comparison study that found 0.6 mm equally effective as 1.2 mm. For patients who prefer at-home treatment with shorter needles, this is genuinely encouraging news.
What The Researchers Did
The research team conducted a systematic search across multiple medical databases (PubMed, Embase, Cochrane Library, CNKI, Wanfang, and VIP) to identify all randomised controlled trials comparing microneedling + 5% minoxidil against 5% minoxidil alone for androgenetic alopecia.
They identified 8 qualifying RCTs involving a total of 472 patients. The data was pooled using standardised statistical methods to assess three key outcomes:
| Outcome | What It Measures | Why It Matters |
|---|---|---|
| Hair count | Number of hairs per defined scalp area | Direct measure of new hair growth |
| Hair diameter | Thickness of individual hair shafts | Indicates whether existing hairs are getting thicker |
| Subgroup analyses | Results split by needle depth and duration | Identifies optimal treatment parameters |
This sits at the very top of the medical evidence hierarchy. A systematic review methodically finds all relevant studies using strict search criteria (so no important research is missed). A meta-analysis then combines the numerical data from those studies using statistical techniques, producing a single pooled result that is more reliable than any individual study. By including only randomised controlled trials (where patients are randomly assigned to treatment groups), the analysis minimises the risk of bias. With 472 patients across 8 trials, this provides substantially more statistical power than any single study.
What They Found
1. Significant hair count improvement
This is the primary finding and it is unequivocal. Across all 8 studies, the addition of microneedling to minoxidil produced significantly more hair regrowth. The confidence interval (12.34–19.31) does not cross zero, meaning we can be confident the effect is real and not due to chance.
2. No improvement in hair diameter
This is an important nuance. Microneedling's primary benefit appears to be recruiting new hairs into the growth cycle rather than thickening existing ones. For patients whose main concern is thinning (rather than total hair count), microneedling may need to be combined with treatments that specifically address hair calibre.
3. Shallower needles produced better results
This is the most practically important finding in this meta-analysis. It suggests that you do not need deep, painful clinical-grade microneedling to get the best results. Shallower needles (which are safer, less painful, and more suitable for home use) may actually be more effective. This is consistent with the Faghihi 2021 study that directly compared depths and found 0.6 mm as effective as 1.2 mm. Our guide to the best derma stamp for hair growth compares the stamps sold for home use.
4. 12 weeks showed stronger effects than longer treatment
This does not mean that 12 weeks is "better" than longer treatment: it means the most rapid improvement occurs in the first 12 weeks, after which the rate of improvement may slow. Think of it as the biggest gains coming early, with continued but more gradual improvement thereafter. The Gupta 2022 meta-analysis found that longer treatment duration positively influenced outcomes overall, suggesting continued benefit with sustained use.
Why Shallower Needles May Work Better
1. Optimal stimulation without excessive damage
Hair follicle stem cells reside in the bulge region, which sits at approximately 0.5–1.0 mm depth in the scalp. Needles under 1 mm reach this critical zone without penetrating deeper into the subcutaneous tissue, where they may cause unnecessary injury. Shallower needles create an optimal balance: enough disruption to trigger the wound healing cascade, without so much damage that healing diverts resources from hair growth.
2. Enhanced drug absorption is depth-independent
One of microneedling's key mechanisms is creating channels for topical absorption. Research suggests that even very shallow needles (0.25–0.5 mm) can significantly enhance transdermal drug delivery by disrupting the stratum corneum barrier. Deeper needles may not substantially improve absorption beyond what shallower needles achieve.
3. Faster recovery allows more frequent treatment
Shallower treatments cause less tissue damage and heal faster, potentially allowing more frequent sessions without accumulated scalp trauma. The Gupta 2022 meta-analysis found that reducing session frequency positively influenced outcomes, suggesting that the quality of each healing response matters more than the intensity of each session.
4. Growth factor release may plateau
The wound healing cascade releases growth factors (PDGF, VEGF, EGF, FGF) proportional to the injury, but there may be a ceiling effect. Beyond a certain depth, additional injury does not produce proportionally more growth factors. Shallower needles may reach this ceiling with less trauma and pain.
Putting the Numbers in Context
| Meta-Analysis | Studies | Patients | Hair Count Effect (MN + topical vs topical alone) |
|---|---|---|---|
| Xu 2024 (this study) | 8 RCTs | 472 | Mean difference: 15.82 hairs (p < 0.05) |
| Gupta 2022 | Multiple | Pooled | β = 12.29 (p < 0.001): MN vs minoxidil |
| Pei 2024 | 13 RCTs | 696 | Significantly superior for density and thickness |
| Abdi 2023 | Multiple | Pooled | MN + minoxidil significantly superior |
The direction of the finding is now unanimous across every published meta-analysis: microneedling + topical treatment significantly outperforms topical treatment alone. What Xu et al. uniquely contribute is the subgroup evidence that shallower needles and 12-week protocols show the strongest effects: practical insights that help patients and clinicians choose the right protocol.
The +15.82-hair mean difference points the same way as individual trials such as the Dhurat 2013 study (+69.2 additional hairs/cm² vs minoxidil alone): both favour adding microneedling to minoxidil, and a single trial often shows a larger effect than a pooled average.
How This Study Compares
| Study | Year | Unique Contribution |
|---|---|---|
| Dhurat et al. | 2013 | First RCT: proved the concept with a single trial (n=94) |
| Gupta et al. | 2022 | First meta-analysis: confirmed MN > minoxidil using regression |
| Faghihi et al. | 2021 | First depth comparison: 0.6 mm = 1.2 mm in a direct trial |
| Xu et al. (this study) | 2024 | First depth + duration subgroup analysis across pooled RCTs |
| Pei et al. | 2024 | Largest meta-analysis (696 patients) confirming combination superiority |
| Parameter | Evidence-Based Recommendation | Supporting Data |
|---|---|---|
| Needle depth | Under 1 mm (e.g., 0.5–0.75 mm) | SMD 1.16 vs 0.52 for >1 mm |
| Treatment duration | Minimum 12 weeks; continue for sustained improvement | SMD 1.08 at 12 weeks; still significant at 21–24 weeks |
| Topical combination | Minoxidil 5% (studied); copper peptide serums (emerging evidence) | All 8 RCTs used minoxidil 5% |
| Session frequency | Weekly to fortnightly (most common in included studies) | Varies by study |
Important: These parameters are derived from the pooled analysis but may not represent the ideal protocol for every individual. Consult a dermatologist to determine the appropriate approach for your specific type and severity of hair loss.
Research Limitations
- Moderate sample size: 472 patients across 8 studies is a reasonable but not large evidence base. Larger multi-centre trials would strengthen confidence in the subgroup findings
- Heterogeneity between studies: The included studies varied in their protocols (device type, frequency, duration, populations), which introduces variability into the pooled estimates
- All studies combined MN with minoxidil: This meta-analysis only tested microneedling + minoxidil vs minoxidil alone. It did not assess microneedling combined with other topicals (e.g., copper peptides, PRP)
- Hair diameter not improved: The finding that hair diameter did not change (p = 0.879) suggests microneedling primarily increases hair count rather than thickening existing hairs. Patients seeking thicker hair may need additional interventions
- Subgroup sample sizes: When the 8 studies are split into subgroups (by depth or duration), each subgroup contains fewer studies, reducing statistical power
- Geographic concentration: Several included studies were conducted in Asian populations. Results may vary across ethnic groups with different hair characteristics
- No long-term follow-up analysis: The longest studies ran 24 weeks. Whether microneedling benefits persist beyond 6 months was not assessed
What This Means for Your Hair
This meta-analysis provides two key practical insights that directly affect treatment decisions:
1. You probably do not need deep needling. The data clearly shows that needles under 1 mm produced better results than deeper needles. For at-home use, this means a 0.5–0.75 mm dermaroller or dermapen may be optimal: safer, less painful, and potentially more effective than the 1.5 mm clinical depth used in earlier studies like Dhurat 2013.
2. Start seeing results by 12 weeks. The strongest improvement signal appeared at 12 weeks (3 months), confirming this as the minimum commitment period. Do not judge your microneedling protocol before completing at least 12 weeks of consistent treatment.
For the best evidence-based approach, combine microneedling with proven topical treatments. While this meta-analysis studied minoxidil specifically, the principle of enhanced absorption applies to any active ingredient. Research on AHK-Cu copper peptides and GHK-Cu shows these ingredients stimulate follicle growth through different pathways than minoxidil. The Kuceki 2025 study demonstrated that combining microneedling with copper peptide serums produced significant improvement even in treatment-resistant cases.
Key Terms Explained
- Standardised Mean Difference (SMD)
- A statistical measure used in meta-analyses to compare results across studies that may use different measurement scales. In this study the subgroup results are SMDs (for example 1.16 for needles under 1 mm), and values above 0.8 are generally considered "large" effects. The headline figure of 15.82 is not an SMD: the paper's results section reports it as a mean difference in hair count.
- 95% Confidence Interval (CI)
- A range of values within which we are 95% confident the true effect lies. For the hair count result (CI: 12.34–19.31), this means the true improvement is very likely between 12.3 and 19.3 additional hairs per square inch. If this range does not include zero, the result is statistically significant.
- Randomised Controlled Trial (RCT)
- A study where participants are randomly assigned to receive either the treatment or a control/comparison intervention. Randomisation minimises selection bias and ensures that differences in outcomes can be attributed to the treatment itself.
- Subgroup Analysis
- A method of examining whether results differ across predefined patient groups or treatment parameters. In this meta-analysis, the researchers split results by needle depth (<1 mm vs >1 mm) and treatment duration (12 weeks vs 21–24 weeks) to identify which protocols work best.
- Hair Count vs Hair Diameter
- Two distinct measures of treatment response. Hair count measures the number of individual hairs in a defined area (more hairs = more coverage). Hair diameter measures the thickness of each hair shaft (thicker hairs = more visible volume). Microneedling improved count but not diameter in this analysis.
- Stratum Corneum
- The outermost layer of skin that acts as a barrier to topical treatments. Microneedling temporarily disrupts this barrier, allowing active ingredients to penetrate deeper into the skin and reach the hair follicle more effectively.
- Bulge Region
- The area of the hair follicle (approximately 0.5–1.0 mm below the skin surface) where hair follicle stem cells reside. Reaching these stem cells is thought to be important for triggering new hair growth.
- Heterogeneity
- The degree of variation between studies included in a meta-analysis. High heterogeneity means studies showed very different results; low heterogeneity means results were consistent. Some heterogeneity is expected when studies use different protocols and populations.
Further Reading
- Our hair mesotherapy guide
- Everything on copper peptides for hair growth
- Copper peptide serums for hair growth: our buyer's guide
For more peer-reviewed studies on hair loss and copper peptide therapy, see our full research hub.
Frequently Asked Questions
Does this mean I should use a 0.5 mm dermaroller instead of a 1.5 mm one?
The meta-analysis found that needles under 1 mm produced a larger pooled effect (SMD: 1.16) than needles over 1 mm (SMD: 0.52). Combined with the Faghihi 2021 study that directly compared 0.6 mm to 1.2 mm and found no significant difference, the evidence increasingly supports shorter needles. A 0.5–0.75 mm depth appears to be a reasonable choice that balances effectiveness with safety and comfort. However, this is based on subgroup analysis (which has less statistical power than the overall finding), so it should be interpreted with appropriate caution.
Why didn't microneedling increase hair thickness?
Hair diameter (thickness) is primarily determined by the size of the hair follicle and hormonal factors like DHT sensitivity. Microneedling appears to work mainly by activating dormant follicles to re-enter the growth cycle (producing new hairs) rather than changing the fundamental size of existing follicles. To increase hair thickness, you may need treatments that address hormonal miniaturisation directly, such as finasteride (which blocks DHT) or topical treatments that stimulate dermal papilla cell growth. Note that the Pei 2024 meta-analysis did find improvements in hair thickness, so this may depend on the specific protocols and topicals used.
Should I stop microneedling after 12 weeks?
No. The finding that 12 weeks showed a larger effect size (SMD: 1.08) than 21–24 weeks (SMD: 0.64) does not mean treatment becomes ineffective after 12 weeks. It means the most rapid improvement occurs early, with continued but more gradual benefit thereafter. The Gupta 2022 meta-analysis specifically found that longer treatment duration was positively associated with better outcomes. Most dermatologists recommend an initial 12-week intensive phase followed by ongoing maintenance therapy.
How many extra hairs does the 15.82 result mean in practice?
The paper reports 15.82 as a mean difference in hair count: on average, about 16 more hairs than with minoxidil alone, counted in a one-square-inch area of the crown. The Dhurat 2013 study found an even larger difference (+69.2 hairs/cm²), though this individual study result is higher than the pooled average.
Can I use copper peptide serums instead of minoxidil with microneedling?
This meta-analysis only studied microneedling combined with minoxidil, so it cannot directly answer this question. However, the Kuceki 2025 study demonstrated significant improvement when combining microneedling with copper peptide formulations, and the biological rationale is strong: copper peptides promote follicle growth through complementary pathways to minoxidil. The micro-channels created by microneedling enhance absorption of any topical active ingredient, making it a logical delivery method for copper peptide serums.
Is this study as reliable as the Pei 2024 meta-analysis with 696 patients?
The Pei 2024 meta-analysis has a larger total patient pool (696 vs 472), giving it more overall statistical power. However, Xu 2024 offers something Pei did not: detailed subgroup analyses by needle depth and treatment duration. The two meta-analyses are complementary: Pei confirms the overall effect with greater certainty, while Xu provides practical guidance on optimal parameters. Both reach the same conclusion: microneedling + topical treatment is significantly superior to topical treatment alone.
Does microneedling work for female pattern hair loss too?
Most studies in this meta-analysis focused on male androgenetic alopecia. However, the mechanisms by which microneedling works (growth factor release, stem cell activation, enhanced drug delivery) are not gender-specific. The Pei 2024 meta-analysis included female participants and confirmed microneedling's benefits. For female-specific approaches, the Moftah 2013 study examined scalp treatment for female hair loss with positive results.
How does this compare to PRP (platelet-rich plasma) for hair loss?
A network meta-analysis (published in Skin Appendage Disorders, 2023) ranked the combination of microneedling + 5% minoxidil highest for efficacy (SUCRA = 95.8%), outperforming PRP alone (which ranked lower). This suggests that microneedling + topical treatment may be more effective than PRP for most patients. However, microneedling + PRP is also being studied as a promising combination, and some clinicians use all three approaches together for maximum benefit.
Xu C, Duan X, Yin Q, Liu K. Effect of Microneedle on Hair Regrowth in Patients with Androgenetic Alopecia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Chinese Medicine and Natural Products. 2024;4(1):e8-e17. doi:10.1055/s-0044-1782181.
Hairgenetix Research Hub. "Microneedling + Topical Treatment: 16 Extra Hairs (2024 Meta-Analysis): A Plain-Language Summary of Xu et al. (2024)." Hairgenetix, 2025. Available at: https://hairgenetix.com/blogs/articles/microneedling-topical-treatment-meta-analysis-xu-2024
